MAPK1 and gastric cancer: In vitro, by directly affecting the expression of mitogen-activated protein kinase 1 (MAPK1), miR-633 can inhibit proliferation, invasion, and migration of gastric cancer cells; arrest the cell cycle in the G1 phase; and induce apoptosis by regulating several genes, including HMGB3 [203].